← FDA Drug Approvals (Drugs@FDA)

MYLOTARG

BLA · Biologics License Application · Sponsor: WYETH PHARMS INC · Approved 2017-09-01

Drug application

FDA Application #
BLA761060
Application type
Biologics License Application
Brand name
MYLOTARG
Generic name
GEMTUZUMAB OZOGAMICIN
Active ingredients
GEMTUZUMAB OZOGAMICIN
Dosage form
VIAL
Route
SINGLE-DOSE
Marketing status
Prescription
Sponsor
WYETH PHARMS INC
Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
First approval
2017-09-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown